Life Sciences as a Long-Cycle Asset: A Family Office Perspective
Explore Life Sciences as a stage-based asset class for WA Family Offices. Join us 19 March at The Westin Perth for this bespoke briefing.
Life Sciences as an Asset Class: A Framework for WA Family Offices
Life sciences is frequently misunderstood by family offices as either too technical to assess or primarily philanthropic. In practice, it is a long-cycle, stage-based asset class that mirrors the capital philosophy of the resources sector. This 2.5-hour session is designed to equip Principals, CIOs, and Investment Leads with clear decision frameworks to translate clinical and regulatory milestones into the familiar language of staged deployment, optionality, and risk mitigation.
The session will feature:
- Strategic Framing: Translating life sciences into the "capital language" of WA investors (milestones, staging, and downside protection).
- Expert Panel & Fireside Chat: Insights from Family Office representatives and industry leaders on pacing capital and separating impact from return.
- Risk & Governance Reality Check: A deep dive into where non-specialist capital underperforms and how disciplined capital builds conviction.
The session will conclude with a networking opportunity to discuss portfolio fit and governance with peers.
Please note: This event is designed for investors and family office principals. It is not a forum for founders seeking capital or technical/scientific deep dives.
Terms and Conditions
By registering for this event you agree to the terms and conditions set out by AusBiotech.
Explore Life Sciences as a stage-based asset class for WA Family Offices. Join us 19 March at The Westin Perth for this bespoke briefing.
Life Sciences as an Asset Class: A Framework for WA Family Offices
Life sciences is frequently misunderstood by family offices as either too technical to assess or primarily philanthropic. In practice, it is a long-cycle, stage-based asset class that mirrors the capital philosophy of the resources sector. This 2.5-hour session is designed to equip Principals, CIOs, and Investment Leads with clear decision frameworks to translate clinical and regulatory milestones into the familiar language of staged deployment, optionality, and risk mitigation.
The session will feature:
- Strategic Framing: Translating life sciences into the "capital language" of WA investors (milestones, staging, and downside protection).
- Expert Panel & Fireside Chat: Insights from Family Office representatives and industry leaders on pacing capital and separating impact from return.
- Risk & Governance Reality Check: A deep dive into where non-specialist capital underperforms and how disciplined capital builds conviction.
The session will conclude with a networking opportunity to discuss portfolio fit and governance with peers.
Please note: This event is designed for investors and family office principals. It is not a forum for founders seeking capital or technical/scientific deep dives.
Terms and Conditions
By registering for this event you agree to the terms and conditions set out by AusBiotech.
Good to know
Highlights
- 2 hours 30 minutes
- In person
Location
The Westin Perth
480 Hay Street
Perth, WA 6000
How do you want to get there?
